AB
NPCE icon

Amalgamated Bank’s Neuropace NPCE Stock Holding History

Amalgamated Bank’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-800
Closed -$12K – 2411
2025
Q4 		$12K Buy
800
+328
+69% +$4.39K ﹤0.01% 2344
2025
Q3 		$5K Hold
472
– – ﹤0.01% 2782
2025
Q2 		$5K Hold
472
– – ﹤0.01% 2768
2025
Q1 		$6K Hold
472
– – ﹤0.01% 2601
2024
Q4 		$5K Hold
472
– – ﹤0.01% 2743
2024
Q3 		$3K Hold
472
– – ﹤0.01% 2886
2024
Q2 		$4K Buy
+472
New +$4.76K ﹤0.01% 2869
2022
Q2 		– Sell
-1,156
Closed -$9K – 3146
2022
Q1 		$9K Buy
+1,156
New +$9.97K ﹤0.01% 2977

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Amalgamated Bank's NPCE Position: Q1 2026 in Review

Amalgamated Bank sold out of Neuropace (NPCE) in Q1 2026, closing a stake of 800 shares — an estimated $12K sold.

Amalgamated Bank first reported a position in NPCE in Q1 2022 and held it in 8 quarters. The position peaked at $12K in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Amalgamated Bank reported no remaining Neuropace position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 800 Neuropace shares in Q1 2026, an estimated $12K.
  • Amalgamated Bank first reported a position in Neuropace in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Neuropace position peaked at $12K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.